Skip to main content
SpringerLink
Log in

Retinoblastoma: Diagnosis, Classification and Management

  • Chapter
  • First Online:
Intraocular Tumors

Abstract

Retinoblastoma is the most common primary intraocular malignancy of childhood. Although a potentially fatal disease, its treatment has improved significantly in recent times. While saving life remains the primary goal, there is an increasing trend worldwide towards globe salvage and preservation of vision. This has been made possible since the introduction of intravenous chemotherapy and focal therapy. Targeted routes of drug delivery to the affected eye such as selective intra-arterial and intra-vitreal chemotherapy have been successfully employed. Plaque brachytherapy and external beam radiotherapy have an established role in selected cases. Enucleation is one of the most commonly performed procedures in advanced cases and the importance of post-operative adjuvant therapy in achieving better cure rates in children with high risk histopathological features has been recognized. Orbital disease remains a major challenge for the developing world. Nevertheless, multimodal therapy has improved survival in children with extra-ocular disease. This chapter provides an insight into the diagnosis of retinoblastoma, the various classification systems in use for staging the disease, as well as a brief description of the different treatment options that are available, including recent advances. Knowledge of these aspects is important for the practising ophthalmologist to acquire a clear understanding of the disease, its clinical presentation and management.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bishop JO, Madsen EC. Retinoblastoma. Review of current status. Surv Ophthalmol. 1975;19:342–66.

    CAS  PubMed  Google Scholar 

  2. Albert DM. Historic review of retinoblastoma. Ophthalmology. 1987;94:654–62.

    CAS  PubMed  Google Scholar 

  3. Jackson E. Report of the committee to investigate and revise the classification of certain retinal conditions. Trans Am Ophthalmol Soc. 1926;24:38–9.

    Google Scholar 

  4. Shields CL, Schoenberg E, Kocher K, Shukla SY, Kaliki S, Shields JA. Lesions simulating retinoblastoma (pseudoretinoblastoma) in 604 cases: results based on age at presentation. Ophthalmology. 2013;120:311–6.

    PubMed  Google Scholar 

  5. Chawla B, Seth R, Moksha L. Chemotherapy for ocular cancers. In: Pharmacology of ocular therapeutics. Cham: Springer; 2016. p. 333–58.

    Google Scholar 

  6. Yoshizumi MO, Thomas JV, Smith TR. Glaucoma-inducing mechanisms in eyes with retinoblastoma. Arch Ophthalmol. 1978;96:105–10.

    CAS  PubMed  Google Scholar 

  7. Chawla B, Khurana S, Sen S, Sharma S. Clinical misdiagnosis of retinoblastoma in Indian children. Br J Ophthalmol. 2014;98:488–93.

    PubMed  Google Scholar 

  8. Chawla B, Hada M, Seth R, Sen S, Gupta V, Kashyap S, et al. Trabeculectomy in eyes with unsuspected retinoblastoma. Ophthalmic Genet. 2016;12:1–4.

    Google Scholar 

  9. Shields J, Shields C. Retinoblastoma: diagnostic approaches. In: Shields J, Shields C, editors. Atlas of intraocular tumors. 3rd ed. Philadelphia: Lippincott, Wolters Kluwer; 2016.

    Google Scholar 

  10. Moulin AP, Gaillard MC, Balmer A, Munier FL. Ultrasound biomicroscopy evaluation of anterior extension in retinoblastoma: a clinicopathological study. Br J Ophthalmol. 2011;96:337–40.

    PubMed  Google Scholar 

  11. Vasquez LM, Giuliari GP, Halliday W, Pavlin CJ, Gallie BL, Héon E. Ultrasound biomicroscopy in the management of retinoblastoma. Eye. 2011;25:141–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Rootman DB, Gonzalez E, Mallipatna A, Vandenhoven C, Hampton L, Dimaras H, et al. Hand-held high-resolution spectral domain optical coherence tomography in retinoblastoma: clinical and morphologic considerations. Br J Ophthalmol. 2013;97:59–65.

    PubMed  Google Scholar 

  13. Chawla B, Sharma S, Sen S, Azad R, Bajaj MS, Kashyap S, et al. Correlation between clinical features, MRI and histopathologic findings in retinoblastoma: a prospective study. Ophthalmology. 2012;119:850–6.

    PubMed  Google Scholar 

  14. de Jong MC, de Graaf P, Noij DP, Göricke S, Maeder P, Galluzzi P, et al. Diagnostic performance of magnetic resonance imaging and computed tomography for advanced retinoblastoma: a systematic review and meta-analysis. Ophthalmology. 2014;121:1109–18.

    PubMed  Google Scholar 

  15. Chawla B, Duraipandi K, Sharma S. MRI in retinoblastoma associated orbital cellulitis. Ophthalmology. 2013;120:1308–9.

    PubMed  Google Scholar 

  16. Reese AB, Ellsworth RM. The evaluation and current concept of retinoblastoma therapy. Trans Am Acad Ophthalmol Otolaryngol. 1963;67:164–72.

    CAS  PubMed  Google Scholar 

  17. Linn Murphree A. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin N Am. 2005;18:41–53.

    CAS  Google Scholar 

  18. Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, et al. The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology. 2006;113:2276–80.

    PubMed  Google Scholar 

  19. Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, et al., editors. Retinoblastoma. In: AJCC cancer staging manual. 8th ed. New York: Springer; 2017. p. 819–31.

    Google Scholar 

  20. Chantada G, Doz F, Antoneli CB, Grundy R, Clare Stannard FF, Dunkel IJ, et al. A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer. 2006;47:801–5.

    PubMed  Google Scholar 

  21. Abramson DH, Schefler AC. Transpupillary thermotherapy as initial treatment for small intraocular retinoblastoma: technique and predictors of success. Ophthalmology. 2004;111:984–91.

    PubMed  Google Scholar 

  22. Shields CL, Santos MC, Diniz W, Gunduz K, Mercado G, Cater JR, et al. Thermotherapy for retinoblastoma. Arch Ophthalmol. 1999;117:885–93.

    CAS  PubMed  Google Scholar 

  23. Hilderbrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T, et al. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol. 2002;43:33–56.

    Google Scholar 

  24. Ohtsubo T, Saito H, Tanaka N, Tsuzuki H, Saito T, Kano E. In vitro effect of hyperthermia on chemoenhancement and uptake of cisplatin in human pharyngeal carcinoma KB cells. Chemotherapy. 1997;43:43–50.

    CAS  PubMed  Google Scholar 

  25. Shields JA, Shields CL, Parsons H, Giblin ME. The role of photocoagulation in the management of retinoblastoma. Arch Ophthalmol. 1990;108:205–8.

    CAS  PubMed  Google Scholar 

  26. Shields JA. The expanding role of laser photocoagulation for intraocular tumors. The 1993 H. Christian Zweng Memorial Lecture. Retina. 1994;14:310–22.

    CAS  PubMed  Google Scholar 

  27. Shields CL, Shields JA, Kiratli H, De Potter PV. Treatment of retinoblastoma with indirect ophthalmoscope laser photocoagulation. J Pediatr Ophthalmol Strabismus. 1995;32:317–22.

    CAS  PubMed  Google Scholar 

  28. Murphree AL, Villablanca JG, Deegan WF, Sato JK, Malogolowin M, Fisher A, et al. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol. 1996;114:1348–56.

    CAS  PubMed  Google Scholar 

  29. Murphree AL, Munier FL. Retinoblastoma. In: Ryan SJ, editor. Retina. 2nd ed. St Louis: Mosby Year Book Inc.; 1994. p. 605–6.

    Google Scholar 

  30. Abramson DH, Ellsworth RM, Rozakis GW. Cryotherapy for retinoblastoma. Arch Ophthalmol. 1982;100:1253–6.

    CAS  PubMed  Google Scholar 

  31. Shields JA, Parsons H, Shields CL, Giblin ME. The role of cryotherapy in the management of retinoblastoma. Am J Ophthalmol. 1989;108:260–4.

    CAS  PubMed  Google Scholar 

  32. Kingston JE, Hungerford JL, Madreperla SA, Plowman PN. Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol. 1996;114:1339–43.

    CAS  PubMed  Google Scholar 

  33. Gallie BL, Budning A, DeBoer G, Thiessen JJ, Koren G, Verjee Z, et al. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch Ophthalmol. 1996;114:1321–8.

    CAS  PubMed  Google Scholar 

  34. Shields CL, De Potter P, Himelstein BP, Shields JA, Meadows AT, Maris JM. Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol. 1996;114:1330–8.

    CAS  PubMed  Google Scholar 

  35. Friedman DL, Himelstein B, Shields CL, Shields JA, Needle M, Miller D, et al. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol. 2000;18:12–7.

    CAS  PubMed  Google Scholar 

  36. Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Naduvilath TJ. Chemoreduction for unilateral retinoblastoma. Arch Ophthalmol. 2002;120:1653–8.

    PubMed  Google Scholar 

  37. Chan HS, De Boer G, Thiessen JJ, Budning A, Kingston JE, O’Brien JM, et al. Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation. Clin Cancer Res. 1996;2:1499–508.

    CAS  PubMed  Google Scholar 

  38. Rodriguez-Galindo C, Wilson MW, Haik BG, Merchant TE, Billups CA, Shah N, et al. Treatment of intraocular retinoblastoma with vincristine and carboplatin. J Clin Oncol. 2003;21:2019–25.

    CAS  PubMed  Google Scholar 

  39. Chawla B, Jain A, Azad R. Conservative treatment modalities in retinoblastoma. Indian J Ophthalmol. 2013;61:479–85.

    PubMed  PubMed Central  Google Scholar 

  40. Chawla B, Jain A, Seth R, Azad R, Mohan VK, Pushker N, et al. Clinical outcome and regression patterns of retinoblastoma treated with systemic chemoreduction and focal therapy: a prospective study. Indian J Ophthalmol. 2016;64:524–9.

    PubMed  PubMed Central  Google Scholar 

  41. Le Deley MC, Vassal G, Taibi A, Shamsaldin A, Leblanc T, Hartmann O. High cumulative rate of secondary leukemia after continuous etoposide treatment for solid tumors in children and young adults. Pediatr Blood Cancer. 2005;45:25–31.

    PubMed  Google Scholar 

  42. Bayar E, Robinson MG, Kurczynski TW. Unilateral retinoblastoma with acquired monosomy 7 and secondary acute myelomonocytic leukemia. Cancer Genet Cytogenet. 1998;105:79–82.

    CAS  PubMed  Google Scholar 

  43. Chan HS, Héon E, Budning A. Improvement of the cure rate of intraocular retinoblastoma without significantly increasing toxicity with higher dose carboplatin teniposide in a cyclosporine multidrug reversal regimen. In: Presented at the 10th international symposium on Retinoblastoma. Florida: Fort Lauderdale. p. 2001.

    Google Scholar 

  44. Villablanca JG. Clinical outcome of group V eyes treated with cyclosporine A/carboplatin/etoposide/vincristine. In: Presented at the 10th international symposium on Retinoblastoma. Florida: Fort Lauderdale. p. 2001.

    Google Scholar 

  45. Leng T, Cebulla CM, Schefler AC, Murray TG. Focal periocular carboplatin chemotherapy avoids systemic chemotherapy for unilateral, progressive retinoblastoma. Retina. 2010;30:S66–8.

    PubMed  Google Scholar 

  46. Abramson DH, Frank CM, Dunkel IJ. A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma. Ophthalmology. 1999;106:1947–50.

    CAS  PubMed  Google Scholar 

  47. Villablanca JG, Jubran RF, Murphree LA. Phase I study of subtenon carboplatin with systemic high dose carboplatin/etoposide/vincristine for eyes with disseminated intraocular Retinoblastoma. In: Presented at the 10th international symposium on retinoblastoma. Florida: Fort Lauderdale. p. 2001.

    Google Scholar 

  48. Shields CL, Shields JA. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy. Curr Opin Ophthalmol. 2010;21:203–12.

    PubMed  Google Scholar 

  49. Mulvihill A, Budning A, Jay V, Vandenhoven C, Héon E, Gallie BL, et al. Ocular motility changes after subtenon carboplatin chemotherapy for retinoblastoma. Arch Ophthalmol. 2003;121:1120–4.

    CAS  PubMed  Google Scholar 

  50. Schmack I, Hubbard GB, Kang SJ, Aaberg TM Jr, Grossniklaus HE. Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for intraocular retinoblastoma. Am J Ophthalmol. 2006;142:310–5.

    CAS  PubMed  Google Scholar 

  51. Kiratli H, Kocabeyoglu S, Bilgic S. Severe pseudo-preseptal cellulitis following sub-Tenon’s carboplatin injection for intraocular retinoblastoma. J AAPOS. 2007;11:404–5.

    PubMed  Google Scholar 

  52. Kaneko A, Suzuki S. Eye-preservation treatment of retinoblastoma with vitreous seeding. Jpn J Clin Oncol. 2003;33:601–7.

    PubMed  Google Scholar 

  53. Suzuki S, Kaneko A. Management of intraocular retinoblastoma and ocular prognosis. Int J Clin Oncol. 2004;9:1–6.

    PubMed  Google Scholar 

  54. Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology. 2008;115:1398–404.

    PubMed  Google Scholar 

  55. Gobin YP, Dunkel IJ, Marr BP, Brodie SE, Abramson DH. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. Arch Ophthalmol. 2011;129:732–7.

    PubMed  Google Scholar 

  56. Shields CL, Bianciotto CG, Jabbour P, Ramasubramanian A, Lally SE, Griffin GC, et al. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, sub-retinal seeds, and vitreous seeds. Arch Ophthalmol. 2011;129:1399–406.

    PubMed  Google Scholar 

  57. Abramson DH, Marr BP, Brodie SE, Dunkel I, Palioura S, Gobin YP. Ophthalmic artery chemosurgery for less advanced intraocular retinoblastoma: five year review. PLoS One. 2012;7:e34120.

    CAS  PubMed  PubMed Central  Google Scholar 

  58. Thampi S, Hetts SW, Cooke DL, Stewart PJ, Robbins E, Banerjee A, et al. Superselective intra-arterial melphalan therapy for newly diagnosed and refractory retinoblastoma: results from a single institution. Clin Ophthalmol. 2013;7:981–9.

    PubMed  PubMed Central  Google Scholar 

  59. Tuncer S, Sencer S, Kebudi R, Tanyıldız B, Cebeci Z, Aydın K. Superselective intra-arterial chemotherapy in the primary management of advanced intra-ocular retinoblastoma: first 4-year experience from a single institution in Turkey. Acta Ophthalmol. 2016;94:e644–51.

    PubMed  Google Scholar 

  60. Chen M, Zhao J, Xia J, Liu Z, Jiang H, Shen G, et al. Intra-arterial chemotherapy as primary therapy for retinoblastoma in infants less than 3 months of age: a series of 10 case-studies. PLoS One. 2016;11(8):e0160873.

    PubMed  PubMed Central  Google Scholar 

  61. Abramson DH, Marr BP, Francis JH, Dunkel IJ, Fabius AW, Brodie SE, et al. Simultaneous bilateral ophthalmic artery chemosurgery for bilateral retinoblastoma (tandem therapy). PLoS One. 2016;11(6):e0156806.

    PubMed  PubMed Central  Google Scholar 

  62. Michaels ST, Abruzzo TA, Augsburger JJ, Corrêa ZM, Lane A, Geller JI. Selective ophthalmic artery infusion chemotherapy for advanced intraocular retinoblastoma: CCHMC early experience. J Pediatr Hematol Oncol. 2016;38:65–9.

    CAS  PubMed  Google Scholar 

  63. Bertelli E, Leonini S, Galimberti D, Moretti S, Tinturini R, Hadjistilianou T, et al. Hemodynamic and anatomic variations require an adaptable approach during intra-arterial chemotherapy for intraocular retinoblastoma: alternative routes, strategies, and follow-up. AJNR Am J Neuroradiol. 2016;37:1289–95.

    CAS  PubMed  Google Scholar 

  64. Klufas MA, Gobin YP, Marr B, Brodie SE, Dunkel IJ, Abramson DH. Intra-arterial chemotherapy as a treatment for intraocular retinoblastoma: alternatives to direct ophthalmic artery catheterization. AJNR Am J Neuroradiol. 2012;33:1608–14.

    CAS  PubMed  Google Scholar 

  65. Inomata M, Kaneko A. Chemosensitivity profiles of primary and cultured retinoblastoma cells in a human clonogenic assay. Jpn J Cancer Res. 1987;78:858–68.

    CAS  PubMed  Google Scholar 

  66. Munier FL, Gaillard MC, Balmer A, Soliman S, Podilsky G, Moulin AP, et al. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications. Br J Ophthalmol. 2012;96:1078–83.

    PubMed  Google Scholar 

  67. Shields CL, Manjandavida FP, Arepalli S, Kaliki S, Lally SE, Shields JA. Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results. JAMA Ophthalmol. 2014;132:319–25.

    PubMed  Google Scholar 

  68. Ghassemi F, Shields CL, Ghadimi H, Khodabandeh A, Roohipoor R. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma. JAMA Ophthalmol. 2014;132:936–41.

    PubMed  Google Scholar 

  69. Francis JH, Schaiquevich P, Buitrago E, Del Sole MJ, Zapata G, Croxatto JO, et al. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study. Ophthalmology. 2014;121:1810–7.

    PubMed  Google Scholar 

  70. Smith SJ, Smith BD, Mohney BG. Ocular side effects following intravitreal injection therapy for retinoblastoma: a systematic review. Br J Ophthalmol. 2014;98:292–7.

    PubMed  Google Scholar 

  71. Merchant TE, Gould CJ, Wilson MW, Hilton NE, Rodriguez-Galindo C, Haik BG. Episcleral plaque brachytherapy for retinoblastoma. Pediatr Blood Cancer. 2004;43:134–9.

    PubMed  Google Scholar 

  72. Shields CL, Shields JA, De Potter P, Minelli S, Hernandez C, Brady LW, et al. Plaque radiotherapy in the management of retinoblastoma. Use as a primary and secondary treatment. Ophthalmology. 1993;100:216–24.

    CAS  PubMed  Google Scholar 

  73. Hernandez JC, Brady LW, Shields CL, Shields JA, De Potter P. Conservative treatment of retinoblastoma. The use of plaque brachytherapy. Am J Clin Oncol. 1993;16:397–401.

    CAS  PubMed  Google Scholar 

  74. Shields CL, Shields JA, Cater J, Othmane I, Singh AD, Micaily B. Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors. Ophthalmology. 2001;108:2116–21.

    CAS  PubMed  Google Scholar 

  75. Shields CL, Mashayekhi A, Sun H, Uysal Y, Friere J, Komarnicky L, et al. Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors. Ophthalmology. 2006;113:2087–92.

    PubMed  Google Scholar 

  76. Schueler AO, Fluhs D, Anastassiou G, Jurklies C, Sauerwein W, Bornfeld N. Beta-ray brachytherapy of retinoblastoma: feasibility of a new small-sized ruthenium-106 plaque. Ophthalmic Res. 2006;38:8–12.

    PubMed  Google Scholar 

  77. Abouzeid H, Moeckli R, Gaillard MC, Beck-Popovic M, Pica A, Zografos L, et al. (106) Ruthenium brachytherapy for retinoblastoma. Int J Radiat Oncol Biol Phys. 2008;71:821–8.

    PubMed  Google Scholar 

  78. American Brachytherapy Society - Ophthalmic Oncology Task Force. The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma. Brachytherapy. 2014;13:1–14.

    Google Scholar 

  79. Marees T, Moll AC, Imhof SM, de Boer MR, Ringens PJ, van Leeuwen FE. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. J Natl Cancer Inst. 2008;100:1771–9.

    PubMed  Google Scholar 

  80. Kleinerman RA, Tucker MA, Tarone RE, Abramson DH, Seddon JM, Stovall M, et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol. 2005;23:2272–9.

    PubMed  Google Scholar 

  81. Eldebawy E, Patrocinio H, Evans M, Hashem R, Nelson S, Sidi R, et al. Stereotactic radiotherapy as an alternative to plaque brachytherapy in retinoblastoma. Pediatr Blood Cancer. 2010;55:1210–2.

    PubMed  Google Scholar 

  82. Sethi RV, Shih HA, Yeap BY, Mouw KW, Petersen R, Kim DY, et al. Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy. Cancer. 2014;120:126–33.

    PubMed  Google Scholar 

  83. Chawla B, Hasan F, Azad R, Seth R, Upadhyay AD, Pathy S, et al. Clinical presentation and survival of retinoblastoma in Indian children. Br J Ophthalmol. 2016;100:172–8.

    PubMed  Google Scholar 

  84. National Cancer Institute. Clinical Trials (PDQ). Phase III study of adjuvant vincristine, carboplatin and etoposide or observation only in patients with newly diagnosed retinoblastoma with or without histopathological high-risk features after enucleation. ClinicalTrials.gov registration NCT00335738. Last modified February 25, 2010. Available at http://www.cancer.gov/clinicaltrials/search/view?cdrid_483043&version_health_professional. Accessed August 2, 2011.

  85. Honavar SG, Singh AD, Shields CL, Meadows AT, Demirci H, Cater J, et al. Post enucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthalmol. 2002;120:923–30.

    PubMed  Google Scholar 

  86. Badhu B, Sah SP, Thakur SK, Dulal S, Kumar S, Sood A, et al. Clinical presentation of retinoblastoma in Eastern Nepal. Clin Exp Ophthalmol. 2005;33:386–9.

    PubMed  Google Scholar 

  87. Gündüz K, Müftüoglu O, Günalp I, Unal E, Taçyildiz N. Metastatic retinoblastoma clinical features, treatment, and prognosis. Ophthalmology. 2006;113:1558–66.

    PubMed  Google Scholar 

  88. Antoneli CB, Steinhorst F, de Cássia Braga Ribeiro K, Novaes PE, Chojniak MM, Arias V, et al. Extraocular retinoblastoma: a 13-year experience. Cancer. 2003;98:1292–8.

    PubMed  Google Scholar 

  89. Chantada G, Fandiño A, Casak S, Manzitti J, Raslawski E, Schvartzman E. Treatment of overt extraocular retinoblastoma. Med Pediatr Oncol. 2003;40:158–61.

    PubMed  Google Scholar 

  90. Chantada GL, Guitter MR, Fandiño AC, Raslawski EC, de Davila MT, Vaiani E, et al. Treatment results in patients with retinoblastoma and invasion to the cut end of the optic nerve. Pediatr Blood Cancer. 2009;52:218–22.

    PubMed  Google Scholar 

  91. Chawla B, Hasan F, Seth R, Pathy S, Pattebahadur R, Sharma S, et al. Multimodal therapy for stage III retinoblastoma (international retinoblastoma staging system): a prospective comparative study. Ophthalmology. 2016;123:1933–9.

    PubMed  Google Scholar 

  92. Shields CL, Palamar M, Sharma P, Ramasubramanian A, Leahey A, Meadows AT, et al. Retinoblastoma regression patterns following chemoreduction and adjuvant therapy in 557 tumors. Arch Ophthalmol. 2009;127:282–90.

    PubMed  Google Scholar 

  93. Paquette LB, Miller D, Jackson HA, Lee T, Randolph L, Murphree AL, Panigrahy A. In utero detection of retinoblastoma with fetal magnetic resonance and ultrasound: initial experience. Am J Perinatol Rep. 2012;2:55–62.

    Google Scholar 

  94. Soliman SE, Dimaras H, Khetan V, Gardiner JA, Chan HS, Héon E, et al. Prenatal versus postnatal screening for familial retinoblastoma. Ophthalmology. 2016;123:2610–7.

    PubMed  Google Scholar 

  95. Chawla B, Singh S. Recent advances and challenges in the management of retinoblastoma. Indian J Ophthalmol. 2017;65(2):133–9.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ocular Oncology Service, Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India

    Bhavna Chawla

  2. National Eye Institute, National Institutes of Health, Bethesda, MD, USA

    Bhavna Chawla

Authors
  1. Bhavna Chawla
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Sankara Nethralaya, Chennai, Tamil Nadu, India

    Vikas Khetan

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Chawla, B. (2020). Retinoblastoma: Diagnosis, Classification and Management. In: Khetan, V. (eds) Intraocular Tumors. Springer, Singapore. https://doi.org/10.1007/978-981-15-0395-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-0395-5_1

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-15-0394-8

  • Online ISBN: 978-981-15-0395-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation